FIGURE

Fig. 1

ID

ZDB-FIG-250311-122

Publication

Ni et al., 2025 - Oxymatrine, a novel TLR2 agonist, promotes megakaryopoiesis and thrombopoiesis through the STING/NF-κB pathway

Other Figures

All Figure Page

Back to All Figure Page

Fig. 1

Screening safe concentrations of oxymatrine for the treatment of K-562 and Meg-01 megakaryocyte (MK). (A, B) The Cell Counting Kit-8 (CCK-8) assay for oxymatrine-treated K-562 (A) and Meg-01 (B) MK proliferation. Three different time points and drug concentrations were used to measure the cell proliferation rate (n = 6 per group). (C, D) Detection of lactate dehydrogenase (LDH) release of K-562 (C) and Meg-01 (D) cells treated with different drug concentrations and measured at different time points (n = 6 per group). (E) Representative images of oxymatrine intervened K-562 and Meg-01 cells with various concentration (10, 20, and 40 ?M) for five days (n = 3 per group). Phorbol 12-myristate 13-acetate (PMA) was used as positive control (0.8 nM). Data represent the mean � standard deviation (SD) of six or three independent experiments and are analyzed by one-way analysis of variance (ANOVA) with Dunnett's 154. ?P < 0.05, ??P < 0.01, and ???P < 0.001 vs. the control. FOV: field of view.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ J Pharm Anal